20th Annual Caribbean Dermatology Symposium

20th Annual Caribbean Dermatology Symposium is organized by Global Academy for Medical Education, LLC. This onsite medical conference will be held from Jan 19 - 23, 2021 at Hilton Aruba Caribbean Resort & Casino, Palm Beach, Noord, Aruba.

Accreditation:
Physicians
The University of Louisville School of Medicine assigns this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians will be able to earn the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours granted for this Continuing Nursing Education activity is 20.5 contact hours.  Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

Conference Objectives:
Upon completing this live activity, respondents should be better able to:
• Form an extensive treatment plan for acne patients based on clinical guidelines, incorporating pharmacologic and nonpharmacologic strategies.
• Express the clinical significance of the most recent research on the etiologies and therapy of acne vulgaris.
• Review the topical treatment pipeline for acne.
• Recognize patients at risk for various skin lesions, including actinic and seborrheic keratoses and nonmelanoma skin cancers.
• Define therapeutic approaches to actinic keratosis that optimize efficacy in treating lesions while reducing risk for neoplastic complications
• Distinguish seborrheic keratosis from other skin lesions, particularly melanoma
• Match patients with the most appropriate interventions for the efficient and cosmetically acceptable treatment of SK lesions.
• Outline evidence-based, guideline-driven treatment strategies for patients with AD based on disease severity with the aim of clear or almost clear skin.
• Include artifices for the implementation of novel therapies aimed at blocking the inflammatory mediators of AD.
• Recognize which allergens are likely to be problematic for patients with atopy and integrate patch testing when appropriate
• Discuss the complications and benefits of CAR-T cell therapy in melanoma.
• Distinguish among potential causes of contact dermatitis and the treatment approaches required.
• Describe the multiple entities that are surrounded by the umbrella term “toxic erythema of chemotherapy” (TEC).
• Review the prevention and management of cutaneous AEs associated with chemotherapies and radiation therapy.
• Explain basic approaches to performing a nail unit biopsy.
• Explain surgical methods to treat rhinophyma.
• Employ simple surgical tips for deep wounds, wound under tension, or to improve efficiency and patient satisfaction.
• Employ basic dermoscopy to the assessment of skin lesions.
• Include newer dermoscopy imaging technologies in clinical practice.
• Define evidence-based strategies for the diagnosis and pharmacologic management of hyperhidrosis.
• Specify the data on the current topical anticholinergic agents in the management of hyperhidrosis.
• Identify fundamental characteristics of emerging and afresh authorized agents for treating skin infections such as ABSSTI (acute bacterial skin and soft tissue infections).
• Recognize malignant from nonmalignant suspicious neoplasms.
• Produce a management plan for melanomas at all stages of development.
• Plan treatment strategies appropriate for pediatric patients with common dermatologic conditions
• Recognize characteristics in pediatric patients that suggest increased risk for the conversion of benign moles to dysplastic nevi or melanoma
• Define characteristics of IHs that are more likely to require medical intervention.
• Catalog how to diagnose and treat common pediatric hair diseases.
• Modify the various photodermatoses from other dermatologic conditions whose symptoms manifest in similar ways.
• Explain the algorithm for the diagnosis of photodermatoses.
• Express photoprotection with patients, including pediatric patients and their caregivers.
• Describe the pathophysiology of psoriasis and its associated comorbidities.
• Diagnose and treat patients with psoriasis properly, based on prevailing clinical guidelines.
• Plan treatment strategies that incorporate biologic therapies into the management of appropriately selected patients with psoriasis.
• Optimize routine screening for psoriatic arthritis in patients with psoriasis.
• Design self-education and patient education programs as part of the treatment plan for rosacea treatment.
• Explain appropriate treatment strategies for rosacea, based on individual signs and symptoms as well as knowledge of the indications, efficacy, and risks of available and emerging rosacea therapies.
• Define the presentation, diagnosis, and management of common tropical diseases.

Additional details will be posted as soon as information is available.